Hôpital Erasme
Hospital
Location:
Brussels,
Belgium (BE)
ISNI: 000000008571829X
ROR: https://ror.org/05j1gs298
Show on Map:
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy (2021)
Dietz J, Di Maio VC, de Salazar A, Merino D, Vermehren J, Paolucci S, Kremer A, et al.
Journal article
Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial (2019)
Dalekos G, Invernizzi P, Nevens F, Hans VV, Zigmond E, Andrade RJ, Ben Ari Z, et al.
Conference contribution
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study (2018)
Feagan BG, Panes J, Ferrante M, Kaser A, D'Haens GR, Sandborn WJ, Louis E, et al.
Journal article
nutritionDay: 10 years of growth (2017)
Schindler K, Pichard C, Sulz I, Volkert D, Streicher M, Singer P, Ljungqvist E, et al.
Journal article
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study (2017)
Feagan BG, Sandborn WJ, D'Haens G, Panes J, Kaser A, Ferrante M, Louis E, et al.
Journal article